Zhejiang Tianyu Pharmaceutical Co Ltd
Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of anti-hypertensive, anti-asthmatic, hypoglycemic, hypolipidemic, and anticoagulant series. It provides fine chemicals and CDMO services. Zhejiang Tianyu Pharmaceutical … Read more
Zhejiang Tianyu Pharmaceutical Co Ltd (300702) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.063x
Based on the latest financial reports, Zhejiang Tianyu Pharmaceutical Co Ltd (300702) has a cash flow conversion efficiency ratio of 0.063x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥233.18 Million) by net assets (CN¥3.72 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Tianyu Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Zhejiang Tianyu Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Tianyu Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Tianyu Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Türkiye Sinai Kalkinma Bankasi A.S
OTCGREY:TRKYY
|
0.071x |
|
Red Violet Inc
NASDAQ:RDVT
|
0.100x |
|
EXP WORLD HLDG DL-00001
F:44Y
|
N/A |
|
Juewei Food Co Ltd
SHG:603517
|
0.019x |
|
Sagicor Financial Company Ltd
PINK:SGCFF
|
0.287x |
|
Atlantic China Welding Consumables Inc
SHG:600558
|
0.010x |
|
NACHI-FUJIKOSHI
F:8UM
|
N/A |
|
INDUS Holding AG
PINK:INDHF
|
0.106x |
Annual Cash Flow Conversion Efficiency for Zhejiang Tianyu Pharmaceutical Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Tianyu Pharmaceutical Co Ltd from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.50 Billion | CN¥344.64 Million | 0.099x | +882.72% |
| 2023-12-31 | CN¥3.49 Billion | CN¥-43.90 Million | -0.013x | +9.66% |
| 2022-12-31 | CN¥3.50 Billion | CN¥-48.70 Million | -0.014x | +80.29% |
| 2021-12-31 | CN¥3.71 Billion | CN¥-262.23 Million | -0.071x | -140.30% |
| 2020-12-31 | CN¥3.55 Billion | CN¥622.18 Million | 0.175x | -16.47% |
| 2019-12-31 | CN¥2.04 Billion | CN¥427.84 Million | 0.210x | +286.63% |
| 2018-12-31 | CN¥1.45 Billion | CN¥78.57 Million | 0.054x | -20.98% |
| 2017-12-31 | CN¥1.29 Billion | CN¥88.52 Million | 0.069x | -74.66% |
| 2016-12-31 | CN¥607.31 Million | CN¥164.74 Million | 0.271x | +811.67% |
| 2015-12-31 | CN¥495.77 Million | CN¥14.75 Million | 0.030x | -83.12% |
| 2014-12-31 | CN¥456.22 Million | CN¥80.44 Million | 0.176x | +101.33% |
| 2013-12-31 | CN¥453.68 Million | CN¥39.73 Million | 0.088x | -- |